Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Bram Baert is active.

Publication


Featured researches published by Bram Baert.


Journal of Ethnopharmacology | 2010

Transdermal behaviour of the N-alkylamide spilanthol (affinin) from Spilanthes acmella (Compositae) extracts

Jente Boonen; Bram Baert; Nathalie Roche; Christian Burvenich; B. De Spiegeleer

AIM OF THE STUDY N-Alkylamides are a large group of bioactive molecules found in several plants from the genera Echinacea, Xanthoxylum and Spilanthes. Extracts and formulations derived from these plants are not only orally used, but also applied on the skin as well. However, there is currently no specific information available about the intrinsic local pharmacokinetics of N-alkylamides after topical application on human skin, questioning the role of this mode of administration. The present study investigates the transdermal behaviour of spilanthol, a prominent N-alkylamide. MATERIALS AND METHODS Two pharmaceutically accepted dose solutions (ethanol and propylene glycol based aqueous donor vehicles), combined with three different receptor fluids (PBS, PBS+0.5% HPbetaCD, EtOH/H(2)O (30:70, v/v)), were applied on split-thickness human skin in a Franz diffusion cell (FDC) system. Fundamental permeation characteristics of spilanthol in a solvent-independent way (100% aqueous dose solution) were also obtained using an extrapolation approach with different organic solvent/H(2)O ratios. RESULTS AND CONCLUSIONS We demonstrated for the first time that spilanthol permeates the skin. The following aqueous-extrapolated primary transdermal parameters were obtained (mean+/-SEM): K(p,aq)=3.31 (+/-0.29)x10(-3)cm/h, D(m,aq)=1.86 (+/-0.09)x10(-4)cm(2)/h and K(m,aq)=7.28 (+/-1.59)x10(-1). Partitioning (K(m)) was strongly dependent on the donor solution composition, while diffusion (D(m)) was mainly influenced by the receptor fluid composition.


Journal of Pharmaceutical and Biomedical Analysis | 2009

Adsorption of peptides at the sample drying step : Influence of solvent evaporation technique, vial material and solution additive

Adel Pezeshki; Valentijn Vergote; Sylvia Van Dorpe; Bram Baert; Christian Burvenich; Alexander Popkov; Bart De Spiegeleer

Although the efficient and careful removal of solvent from samples by centrifugal evaporation or freeze-drying methods is an important step in peptidomics, the recovery of peptides has not yet been fully investigated with these sample drying methods. Moreover, the surface adsorption of the peptides by the container and efforts to reduce this adsorption by organic additives is only scarcely elaborated until now. In this experiment, the recovery of five model peptides, i.e. bovine insulin, mouse obestatin, goserelin, buserelin and leucine-enkephalin was investigated applying dimethylsulfoxide (DMSO), dimethylformamide (DMF), polyethylene glycol 400 (PEG 400), mannitol and n-nonyl-beta-d-glucopyranoside (C(9)-Glu) in function of the two applied solvent evaporation processes (freeze-drying vs. centrifugal evaporation) and vial types, i.e. polypropylene (PP) and glass. Under our experimental conditions, drying resulted in a decreased recovery of the model peptides by 10% on average. Insulin showed the lowest recovery value relative to the other model peptides. For both drying methods, recovery of the model peptides was increased when C(9)-Glu was present. Overall, the use of PP vials is proposed for freeze-drying, while glass vials are found to be more suitable for centrifugal evaporation. The presence of PEG 400 in PP vials caused significantly reduced recoveries for all model peptides using centrifugal evaporation, although this was not observed in glass vials. As a general conclusion, applying C(9)-Glu as an additive along with choosing appropriate vial type (i.e. PP for lyophilization and glass for centrifugal evaporation) can avoid or diminish peptide loss during the evaporation procedure.


European Journal of Pharmaceutics and Biopharmaceutics | 2009

Analytical, biopharmaceutical and regulatory evaluation of topical testosterone preparations

Bram Baert; S. Annavarapu; Christian Burvenich; B. De Spiegeleer

Testosterone-containing pharmaceutical products for topical use were obtained from the pharmacist or through the internet. The legal status of the different products obtained is discussed: some products through the internet were clearly a medicinal product according to the current definitions, while they are not registered as such. Assay and impurity profiles of each of the marketed samples were obtained using HPLC-UV and ESI-iontrap MS. The analytical results were evaluated relative to the reporting, identification and qualification thresholds as defined by the the International Conference on Harmonisation (ICH) and the European Pharmacopoeia (Ph. Eur.). Preparations with impurities above the qualification threshold were observed. Moreover, in vitro release profiles over an artificial membrane were obtained using a standardised cell in a paddle dissolution bath as well as in a static Franz diffusion cell, using phosphate buffered saline (PBS; pH 7.0) containing 5% bovine serum albumin (BSA) as dissolution or receptor fluid. This biopharmaceutical quality attribute differs significantly between the preparations tested. In conclusion, the equivalency of topical testosterone preparations is not assured, nor on their legal status, nor on their impurity profiling nor on their biopharmaceutical behaviour. This calls for an urgent trans-national product-class harmonisation approach.


Journal of Dairy Science | 2014

Identification of a microscopically selected microorganism in milk samples

Nathalie Bracke; Mario Van Poucke; Bram Baert; Evelien Wynendaele; Lobke De Bels; Wim Van Den Broeck; Luc Peelman; Christian Burvenich; Bart De Spiegeleer

Identification of unwanted microbial contaminants microscopically observed in food products is challenging due to their low abundance in a complex matrix, quite often containing other microorganisms. Therefore, a selective identification method was developed using laser capture microdissection in combination with direct-captured cell PCR. This procedure was validated with Geobacillus stearothermophilus and further used to identify microbial contaminants present in some industrial milk samples. The microscopically observed contaminants were identified as mainly Methylobacterium species.


Bioorganic & Medicinal Chemistry | 2007

Transdermal penetration behaviour of drugs : CART-clustering, QSPR and selection of model compounds

Bram Baert; Eric Deconinck; Mireille Van Gele; Marián Slodička; Paul Stoppie; Samuel Bodé; Guido Slegers; Yvan Vander Heyden; Jo Lambert; Johan Beetens; Bart De Spiegeleer


Journal of Chromatography B | 2007

Analysis of iodinated peptides by LC-DAD/ESI ion trap mass spectrometry.

Valentijn Vergote; Samuel Bodé; Kathelijne Peremans; H. Vanbree; Bram Baert; Guido Slegers; Christian Burvenich; B. De Spiegeleer


Journal of Pharmaceutical and Biomedical Analysis | 2008

LC-UV/MS characterization and DOE optimization of the iodinated peptide obestatin

Valentijn Vergote; Bram Baert; Eva Vandermeulen; Kathelijne Peremans; Henri van Bree; Guido Slegers; Christian Burvenich; Bart De Spiegeleer


Journal of Pharmaceutical and Biomedical Analysis | 2007

Assessment of the solid-state composition of an active salicylanilide compound by FT-Raman spectroscopy.

B. De Spiegeleer; Bram Baert; N Diericx; D. Seghers; Francis Verpoort; L. Van Vooren; Christian Burvenich; Guido Slegers


Abstracts of presentations at the Eleventh International Perspectives in Percutaneous Penetration Conference held in La Grande Motte March 2008 | 2008

Development of system suitability tests for in vitro skin integrity control: impedance and capacitance.

Bart De Spiegeleer; Bram Baert; Valentijn Vergote; Sylvia Van Dorpe


Pharmazie | 2007

Stability of the OECD model compound benzoic acid in receptor fluids of Franz diffusion cells

Samuel Bodé; Bram Baert; Vangele M; Jo Lambert; Christian Burvenich; Guido Slegers; De Spiegeleer B

Collaboration


Dive into the Bram Baert's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge